Vaccinations in Pregnancy. A Comprehensive Overview
DOI:
https://doi.org/10.12775/JEHS.2024.56.015Keywords
pregnancy, vaccination, vaccination safe in pregnancy, planning a pregnancy, vaccinations contraindicated during pregnancy, vaccinations of women in childbearing ageAbstract
Introduction and purpose
Pregnancy is associated with many changes in the mother's body, allowing for the proper development of the fetus, but unfortunately it also predisposes many potentially harmless infections to become much more severe during pregnancy. Therefore, vaccinations during pregnancy play a very important protective role both for the mother, her unborn child and to the child immediately after birth. Immunization during pregnancy and in the preconception period protects against many infectious diseases and related complications. By receiving the vaccine, specific antibodies are synthesized and transported across the placenta to the fetus. They protect the baby during the first months of life, when the baby cannot receive vaccinations due to its age yet. Vaccinations during pregnancy can be divided into necessary, possible and recommended. Recommended vaccinations include against diphtheria, tetanus, pertussis, influenza, Covid19 and RSV. They are especially recommended for every pregnant woman who has no permanent or temporary contraindications. A special group of vaccinations are those necessary to perform, which play the main role as post-exposure prophylaxis and must be administered immediately after exposure to the agent causing the infection. These include mainly vaccination against tetanus and rabies. The vaccinations that can be performed include those targeted at a specific group of patients with various chronic diseases who are at risk or traveling to countries where there is an increased risk of illness. During a doctor's visit to a woman planning a pregnancy, it is important to collect a detailed interview regarding vaccination history, past infectious infections and chronic diseases. This allows us to prepare an individualized vaccination schedule recommended both before and during pregnancy.
References
Dąbek J, Sierka O, Kulik H, Gąsior Z. Protective vaccinations during pregnancy - adult Poles knowledge in this area. BMC Public Health. 2021 Jul 13;21(1):1392. doi: 10.1186/s12889-021-11336-0. PMID: 34256706; PMCID: PMC8276846.
Fayaz A, Simani S, Fallahian V, Eslamifar A, Hazrati M, Farahtaj F, Howaizi N, Biglari P. Rabies antibody levels in pregnant women and their newborns after rabies post-exposure prophylaxis. Iran J Reprod Med. 2012 Mar;10(2):161-3. PMID: 25242991; PMCID: PMC4163280.
Nitsch-Osuch AS, Bomba-Opon D, Jasik M. Influenza vaccination in pregnancy - current data on safety and effectiveness. Ginekol Pol. 2020;91(10):629-633. doi: 10.5603/GP.a2020.0105. PMID: 33184832.
Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633. Erratum in: JAMA. 2017 Jan 24;317(4):442. Erratum in: JAMA. 2017 Jan 24;317(4):441-442. PMID: 24794369; PMCID: PMC4333147.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. PMID: 34739716; PMCID: PMC8569292.
Guidelines of the Polish Society of Gynecologists and Obstetricians, the Polish Society for Vaccinology, and the Polish Society for Family Medicine on vaccinating women with reproductive plans and pregnant or breastfeeding women. Agnieszka Seremak-Mrozikiewicz, Aneta Nitsch-Osuch, Krzysztof Czajkowski, Krzysztof Drews, Hubert Huras, Jaroslaw Kalinka, Ernest Kuchar, Bozena Leszczynska-Gorzelak, Agnieszka Mastalerz-Migas, Malgorzata Swiatkowska-Freund, Miroslaw Wielgos, Hubert Wolski, Jacek Wysocki, Mariusz Zimmer, Piotr Sieroszewski
DOI: 10.5603/gpl.95834 Pubmed: 37599569 Ginekol Pol 2023;94(8):670-682.
Abdulmoghni RT, Al-Ward AH, Al-Moayed KA, Al-Amad MA, Khader YS. Incidence, Trend, and Mortality of Human Exposure to Rabies in Yemen, 2011-2017: Observational Study. JMIR Public Health Surveill. 2021 Jun 22;7(6):e27623. doi: 10.2196/27623. PMID: 34156339; PMCID: PMC8277343.
Al-Shamahy HA, Sunhope A, Al-Moyed KA. Prevalence of rabies in various species in yemen and risk factors contributing to the spread of the disease. Sultan Qaboos Univ Med J. 2013 Aug;13(3):404-10. doi: 10.12816/0003263. Epub 2013 Jun 25. PMID: 23984026; PMCID: PMC3749025.
Liu C, Cahill JD. Epidemiology of Rabies and Current US Vaccine Guidelines. R I Med J (2013). 2020 Aug 3;103(6):51-53. PMID: 32752569.
WHO technical report series 1012. WHO Expert Consultation on Rabies. Third report. https://www.who.int/publications/i/item/WHO-TRS-1012 https://iris.who.int/bitstream/handle/10665/272364/9789241210218-eng.pdf?sequence=1 67, 69
Federale overheidsdienst Volksgezondheid. Vaccinatie tegen tetanus bij volwassenen. https://www.zorg-en-gezondheid.be/uploadedFiles/NLsite_v2/Ziekten/Vaccinaties/Informatie_voor_vaccinatoren/vaccinatie_fiche_volw_tetanus_06032013(1).pdf.
Donken R, van der Maas N, Swaan C, Wiersma T, Te Wierik M, Hahné S, de Melker H. The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study. BMC Fam Pract. 2014 Jun 9;15:112. doi: 10.1186/1471-2296-15-112. PMID: 24910158; PMCID: PMC4069364.
CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women – Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. 2013; 62 (07):131-5.
Nypaver C, Dehlinger C, Carter C. Influenza and Influenza Vaccine: A Review. J Midwifery Womens Health. 2021 Jan;66(1):45-53. doi: 10.1111/jmwh.13203. Epub 2021 Feb 1. PMID: 33522695; PMCID: PMC8014756.
Oseghale O, Vlahos R, O'Leary JJ, Brooks RD, Brooks DA, Liong S, Selemidis S. Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications. Viruses. 2022 Dec 7;14(12):2729. doi: 10.3390/v14122729. PMID: 36560733; PMCID: PMC9786233.
Antczak A, Kuchar E, Nitsch-Osuch A, et al. Stanowisko Ekspertów Ogólnopolskiego Programu Zwalczania Grypy oraz Polskiego Towarzystwa Ginekologów i Położników dotyczące szczepienia przeciw grypie kobiet
Alhendyani F, Jolly K, Jones LL. Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis. PLoS One. 2022; 17(2): e0263234, doi: 10.1371/journal.pone.0263234, indexed in Pubmed: 35143531.
SAGE updates COVID-19 vaccination guidance https://www.paho.org/en/news/28-3-2023-sage-updates-covid-19-vaccination-guidance
Stanowisko PTGiP dotyczące szczepień kobiet ciężarnych przeciwko COVID19 https://www.ptgin.pl/aktualnosc/stanowisko-ptgip-dotyczace-szczepien-kobiet-ciezarnych-przeciwko-covid19
Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022 Feb;226(2):177-186. doi: 10.1016/j.ajog.2021.08.054. Epub 2021 Sep 14. PMID: 34534497; PMCID: PMC8438995.
COVID-19 vaccination in pregnancy Crossref DOI link: https://doi.org/10.1016/j.ajog.2022.05.020 Published Print: 2022-08 Update policy: https://doi.org/10.1016/elsevier_cm_policy
Ciąża wysokiego ryzyka – czy i kiedy szczepić ciężarną przeciwko grypie i krztuścowi - https://podyplomie.pl/grypa/posts/511.ciaza-wysokiego-ryzyka-czy-i-kiedy-szczepic-ciezarna-przeciwko-grypie-i-krztuscowi?page=2
Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S310-S320. doi: 10.1093/infdis/jiaa469. PMID: 34590129; PMCID: PMC8482022.
Kalendarz szczepień na 2023 rok https://szczepienia.pzh.gov.pl/wp-content/uploads/2022/12/Kalendarz-szczepien-2023.pdf
Fortuna L, Chaithongwongwatthana S, Soonthornworasiri N, Spiegel J, Wijagkanalan W, Mansouri S, van den Biggelaar AHJ, Pham HT. Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand. Vaccine. 2020 Dec 3;38(51):8194-8199. doi: 10.1016/j.vaccine.2020.10.070. Epub 2020 Nov 8. PMID: 33176935.
FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants
European Health Union: Commission authorises first vaccine to protect infants from respiratory syncytial virus (RSV) infections https://ec.europa.eu/commission/presscorner/detail/en/mex_23_4261
ANEKS I CHARAKTERYSTYKA PRODUKTU LECZNICZEGO https://ec.europa.eu/health/documents/community-register/2023/20230823160227/anx_160227_pl.pdf
Szczepionka przeciwko RSV zatwierdzona do stosowania u kobiet ciężarnych https://infekcje.mp.pl/choroby/rsv/329998,szczepionka-przeciwko-rsv-zatwierdzona-do-stosowania-u-kobiet-ciezarnych
Zakażenia RSV – objawy, leczenie, powikłania https://www.mp.pl/pacjent/choroby-zakazne/choroby/zakazenia-wirusowe/321332,zakazenia-rsv-objawy-leczenie-powiklania
CDC. Pertussis. In Hamborsky J, et al, eds. Epidemiology and Prevention of Vaccine-Preventable Disease; Public Health Foundation; The Pink Book: Course Textbook - 14th Edition (2021) https://www.cdc.gov/vaccines/pubs/pinkbook/pert.html
CDC. Meningococcal Disease. Sarah Mbaeyi, MD; Jonathan Duffy, MD, MPH; Lucy A. McNamara, PhD. Epidemiology and Prevention of Vaccine-Preventable Disease; Public Health Foundation; The Pink Book: Course Textbook - 14th Edition (2021) https://www.cdc.gov/vaccines/pubs/pinkbook/mening.html#print
Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep 2020;69(No. RR-9):1–41. DOI: http://dx.doi.org/10.15585/mmwr.rr6909a1
Arora M, Lakshmi R. Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021 Oct;76:23-40. doi: 10.1016/j.bpobgyn.2021.02.002. Epub 2021 Feb 19. PMID: 33773923; PMCID: PMC7992376.
CDC. Pneumoococcal Disease. Ryan Gierke, MPH; A. Patricia Wodi, MD; and Miwako Kobayashi, MD, MPH Epidemiology and Prevention of Vaccine-Preventable Disease; Public Health Foundation; The Pink Book: Course Textbook - 14th Edition (2021) https://www.cdc.gov/vaccines/pubs/pinkbook/pneumo.html
Abu Raya B, Sadarangani M. Meningococcal vaccination in pregnancy. Hum Vaccin Immunother. 2018 May 4;14(5):1188-1196. doi: 10.1080/21645515.2018.1445447. Epub 2018 Mar 21. PMID: 29485347; PMCID: PMC5989878.
Chaudhry SA, Koren G. Hepatitis A infection during pregnancy. Can Fam Physician. 2015 Nov;61(11):963-4. PMID: 26881283; PMCID: PMC4642904.
Veronese P, Dodi I, Esposito S, Indolfi G. Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol. 2021 Jul 14;27(26):4182-4193. doi: 10.3748/wjg.v27.i26.4182. PMID: 34326618; PMCID: PMC8311536.
CDC. Hepatitis B Penina Haber, MPH and Sarah Schillie, MD, MPH, MBA Epidemiology and Prevention of Vaccine-Preventable Disease; Public Health Foundation; The Pink Book: Course Textbook - 14th Edition (2021) https://www.cdc.gov/vaccines/pubs/pinkbook/hepb.html
BENCSKÓ G, FERENCI T. Effective case/infection ratio of poliomyelitis in vaccinated populations. Epidemiology and Infection. 2016;144(9):1933-1942. doi:10.1017/S0950268816000078
Poliomyelitis Concepcion F. Estivariz, MD; Ruth Link-Gelles, PhD, MPH; and Tom Shimabukuro, MD, MPH, MBA Epidemiology and Prevention of Vaccine-Preventable Disease; Public Health Foundation; The Pink Book: Course Textbook - 14th Edition (2021) https://www.cdc.gov/vaccines/pubs/pinkbook/polio.html
Cristina Masuet-Aumatell, Jorge Atouguia, Typhoid fever infection – Antibiotic resistance and vaccination strategies: A narrative review, Travel Medicine and Infectious Disease, Volume 40, 2021, 101946, ISSN 1477-8939, https://doi.org/10.1016/j.tmaid.2020.101946. (https://www.sciencedirect.com/science/article/pii/S1477893920304439)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ines Plewniok, Monika Maj-Dziedzic, Marcelina Sikora, Marta Zarzycka, Anna Brzozowska, Jeremiasz Dubiel, Adrian Maj, Martyna Warno, Wiktor Kozik, Greta Śmietana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 456
Number of citations: 0